Insider Monkey41d agoneutral
Can AbbVie’s Backing Help ADARx Win Over Biotech IPO Investors at a $1.74 Billion Valuation?Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Insider Monkey46d agoneutral
Nvidia Backed This AI Drug Startup. AbbVie Just Became a Partner Before Its IPOInvestor's Business Daily60d agoneutral
IPO Stock LB Pharma Has Tripled In Under A Year. Is It A Takeover Target?Barrons.com96d agoneutral
AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are OpenMT Newswires100d agoneutral
AbbVie Trims Full-Year Profit Outlook Due to Apogee AcquisitionMotley Fool112d agoneutral
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?Insider Monkey138d agoneutral
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition